13. St. gallen meme kanseri konferansı sonrası değerlendirme “erken evre meme kanseri cerrahisinde yenilikler: Meme koruyucu cerrahi (mkc) ve sentinel lenf nodülü biyopsisi (slnb)”

References (10)

1. Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 2013
2. (PMID:23491275) [CrossRef] 2.Milgrom S, Cody H, Tan L, Morrow M, Pesce C, Setton J, et al. Cha- racteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment. Ann Surg Oncol 2012
3. (PMID: 22576064) [CrossRef] 3.Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blu- mencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011
4. (PMID: 21304082) [CrossRef] 4.Hamdi M, Rasheed MZ. Advances in autologous breast reconstruc- tion with pedicled perforator flaps. Clin Plast Surg 2012
5. (PMID: 23036298) [CrossRef] 5.Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010
6. (PMID: 20194857) [CrossRef] 6.Millar EK, Graham PH, O’Toole SA, McNeil CM, Browne L, Morey AL, et al. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol 2009
7. (PMID: 19720911) [CrossRef] 7.Kiess AP, McArthur HL, Mahoney K, Patil S, Morris PG, Ho A, et al. Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer. Cancer 2012
8. (PMID: 21887681) [CrossRef] 8. Grills IS, Kestin LL, Goldstein N, Mitchell C, Martinez A, Ingold J, et al. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys 2003
9. (PMID: 12788171) [CrossRef] 9. Yates L, Kirby A, Crichton S, Gillett C, Cane P, Fentiman I, et al. Risk factors for regional nodal relapse in breast cancer patients with one to three positive axillary nodes. Int J Radiat Oncol Biol Phys 2012
10. (PMID: 21530101) [CrossRef] 10 Collins ED, Moore CP, Clay KF, Kearing SA, O’Connor AM, Llewell- yn-Thomas HA, et al. Can women with